Efficacy, safety and albuminuria-reducing effect of gemigliptin in Korean type 2 diabetes patients with moderate to severe renal impairment: A 12-week, double-blind randomized study (the GUARD Study).
about
Efficacy, safety and albuminuria-reducing effect of gemigliptin in Korean type 2 diabetes patients with moderate to severe renal impairment: A 12-week, double-blind randomized study (the GUARD Study).
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Efficacy, safety and albuminur ...... mized study (the GUARD Study).
@en
Efficacy, safety and albuminur ...... mized study (the GUARD Study).
@nl
type
label
Efficacy, safety and albuminur ...... mized study (the GUARD Study).
@en
Efficacy, safety and albuminur ...... mized study (the GUARD Study).
@nl
prefLabel
Efficacy, safety and albuminur ...... mized study (the GUARD Study).
@en
Efficacy, safety and albuminur ...... mized study (the GUARD Study).
@nl
P2093
P2860
P356
P1476
Efficacy, safety and albuminur ...... omized study (the GUARD Study)
@en
P2093
Byoung G Han
Hyeong C Park
Kyung H Jeong
Sang Y Han
Seong H Shin
Shin W Kang
Sun A Yoon
Sun H Park
P2860
P304
P356
10.1111/DOM.12863
P577
2017-02-17T00:00:00Z